Biomarkers for mucositis assessment

Pediatric Blood and Cancer

Volumn 53, Issue 7, 2009, Pages 1169-1170

  Baggott, Christina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALGRANULIN; CITRULLINE; DNA; INTERLEUKIN 8; CARBOHYDRATE; DIAGNOSTIC AGENT;

CELL LOSS; CELL MEMBRANE PERMEABILITY; CLINICAL ASSESSMENT; EPITHELIUM CELL; HUMAN; LABORATORY TEST; MUCOSA INFLAMMATION; NOTE; PRIORITY JOURNAL; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; FECES; INTESTINE ABSORPTION; ISOLATION AND PURIFICATION; METABOLISM;

BIOLOGICAL MARKERS; CARBOHYDRATES; CITRULLINE; DNA; FECES; HUMANS; INTERLEUKIN-8; INTESTINAL ABSORPTION; LEUKOCYTE L1 ANTIGEN COMPLEX; MODELS, BIOLOGICAL; MUCOSITIS;

EID: 70449704573     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22258     Document Type: Note

References (3)

1. Elting LS, Cooksley C, Chambers M, et al. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003;98:1531-1539.
2. Tomlinson D, Judd P, Hendershot E, et al. Measurement of oral mucositis in children: A review of the literature. Support Care Cancer 2007;15:1251-1258.
3. World Health Organization Handbook for reporting results of cancer treatment. Geneva; 1979. Report. pp. 15-22.